title: Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival.
abstract: Hepatocellular carcinoma (HCC) accounts for over 90% of all primary liver cancers. With an ever increasing incidence trend year by year, it has become the third most common cause of death from cancer worldwide. Hepatic resection is generally considered to be one of the most effective therapies for HCC patients, however, there is a high risk of recurrence in postoperative HCC. In clinical practice, there exists an urgent need for valid prognostic markers to identify patients with prognosis, hence the importance of studies on prognostic markers in improving the prediction of HCC prognosis. This review focuses on the most promising immunohistochemical prognostic markers in predicting the postoperative survival of HCC patients.
authors.affiliation: Zhao-Shan Niu, Lab of Micromorphology, Medical College of Qingdao University, Qingdao 266071, Shandong Province, China.
authors.forename: Zhao-Shan
authors.initials: ZS
authors.lastname: Niu
authors.affiliation: Zhao-Shan Niu, Lab of Micromorphology, Medical College of Qingdao University, Qingdao 266071, Shandong Province, China.
authors.forename: Xiao-Jun
authors.initials: XJ
authors.lastname: Niu
authors.affiliation: Zhao-Shan Niu, Lab of Micromorphology, Medical College of Qingdao University, Qingdao 266071, Shandong Province, China.
authors.forename: Mei
authors.initials: M
authors.lastname: Wang
keywords: Hepatocellular carcinoma; Immunohistochemical; Management; Predictive marker; Prognostic marker